Nitric Oxide Potentiates Acute Lung Injury in an Isolated Rabbit Lung Model (original) (raw)

1998, The Annals of Thoracic Surgery

Abstract

Background. The effect of inhaled nitric oxide (NO) treatment on pulmonary function in the setting of adult respiratory distress syndrome is controversial. We examined the effect of inhaled NO on pulmonary function in an isolated rabbit lung model of oleic acid (OA)-induced acute lung injury. We hypothesized that NO would decrease pulmonary artery pressure and improve oxygenation. Methods. Rabbit heart-lung blocks were isolated, flushed in vivo, harvested, and immediately perfused with whole blood and ventilated with 50% oxygen (O 2). Pulmonary artery pressure was determined every 15 seconds for 60 minutes of perfusion. Oxygenation was determined by blood gas analysis of pulmonary venous effluent at 0, 20, 40, and 60 minutes after initiation of OA infusion. Rabbits were randomized into four study groups: saline control; OA control, which received a 20-minute infusion of 50% OA/ethanol solution; NO treatment (20 ppm NO inhaled before OA infusion); and NO control, which underwent NO (20 ppm) pretreatment, followed by saline infusion. Pulmonary artery pressure, oxygenation (arteriovenous O 2 difference), compliance, and wet/dry lung weight were determined. Results. Pretreatment with NO caused significant increases in pulmonary artery pressure (NO treatment versus NO control and saline control; no significant difference between NO treatment group and OA control group), and did not improve oxygenation in our model. Conclusions. Contrary to our hypothesis, pretreatment with NO potentiates acute lung injury in our isolated lung model. There was significant exacerbation of pulmonary hypertension and no improvement in oxygenation. Further investigation of the possible deleterious effects of NO in acute lung injury are needed, especially in the early acute phases of this process.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (17)

  1. Zwissler B, Kemming G, Habler O, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory dis- tress syndrome. Am J Respir Crit Care Med 1996;154:1671-7.
  2. Rossetti M, Guenard H, Gabinski C. Effects of nitric oxide inhalation on pulmonary serial vascular resistances in ARDS. Am J Respir Crit Care Med 1996;154:1375-81.
  3. Andresen M, Dougnac A, Castillo L, et al. [Prolonged inha- lation of nitric oxide in adult respiratory distress syndrome in a case]. Rev Med Chile 1996;124:94 -102.
  4. Demirakca S, Dotsch J, Knothe C, et al. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syn- drome: dose response, prolonged inhalation, and weaning. Crit Care Med 1996;24:1913-9.
  5. Betbese AJ, Perez M, Bak E, Ballus J, Net A, Mancebo J. [Gas exchange and hemodynamic effects of nitric oxide inhalation in patients with acute respiratory distress syndrome]. Med Clin 1996;107:201-6.
  6. Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996;109:486-93.
  7. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot- Pocidalo MA, Payen DM. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996;153:985-90.
  8. Lowson SM, Rich GF, McArdle PA, Jaidev J, Morris GN. The response to varying concentrations of inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesth Analg 1996;82:574-81.
  9. McIntyre RC Jr, Moore FA, Moore EE, et al. Inhaled nitric oxide variably improves oxygenation and pulmonary hyper- tension in patients with acute respiratory distress syndrome. Trauma 1995;39:418-25.
  10. Rossaint R, Slama K, Steudel W, et al. Effects of inhaled nitric oxide on right ventricular function in severe acute respira- tory distress syndrome. Intensive Care Med 1995;21:197-203.
  11. Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995;107:1107-15.
  12. Samama CM, Diaby M, Fellahi JL, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995;83: 56-65.
  13. Eichinger MR, Walker BR. Nitric oxide and cGMP do not affect fluid flux in isolated rat lungs. J Appl Physiol 1996;80: 69-76.
  14. Eppinger MJ, Ward PA, Jones ML, Bolling SF, Deeb GM. Disparate effects of nitric oxide on lung ischemia-reperfusion injury. Ann Thorac Surg 1995;60:1169-76.
  15. Putensen C, Rasanen J, Lopez FA, Downs JB. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 1994;106:1563-9.
  16. Shah NS, Nakayama DK, Jacob TD, et al. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg 1994;129:158-64.
  17. Theiss SD, Corbin RS, Goff CD, et al. Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury. Ann Thorac Surg 1996;61:1453-7.